Sotera Health Company (SHC) Revenue & Revenue Breakdown
Sotera Health Company Revenue Highlights
Latest Revenue (Y)
$1.05B
Latest Revenue (Q)
$276.59M
Main Segment (Y)
Service
Main Geography (Y)
UNITED STATES
Sotera Health Company Revenue by Period
Sotera Health Company Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.05B | 4.54% |
| 2022-12-31 | $1.00B | 7.75% |
| 2021-12-31 | $931.48M | 13.85% |
| 2020-12-31 | $818.16M | 5.12% |
| 2019-12-31 | $778.33M | 4.31% |
| 2018-12-31 | $746.15M | - |
Sotera Health Company generated $1.05B in revenue during NA 2023, up 4.54% compared to the previous quarter, and up 140.63% compared to the same period a year ago.
Sotera Health Company Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $276.59M | 11.45% |
| 2024-03-31 | $248.18M | -20.00% |
| 2023-12-31 | $310.24M | 17.88% |
| 2023-09-30 | $263.18M | 3.09% |
| 2023-06-30 | $255.28M | 15.73% |
| 2023-03-31 | $220.59M | -12.32% |
| 2022-12-31 | $251.59M | 1.16% |
| 2022-09-30 | $248.70M | -6.73% |
| 2022-06-30 | $266.64M | 12.62% |
| 2022-03-31 | $236.75M | -1.86% |
| 2021-12-31 | $241.25M | 6.67% |
| 2021-09-30 | $226.16M | -10.22% |
| 2021-06-30 | $251.92M | 18.75% |
| 2021-03-31 | $212.15M | -2.17% |
| 2020-12-31 | $216.84M | 8.41% |
| 2020-09-30 | $200.03M | -6.13% |
| 2020-06-30 | $213.09M | 13.22% |
| 2020-03-31 | $188.20M | -2.73% |
| 2019-12-31 | $193.49M | -0.94% |
| 2019-09-30 | $195.32M | - |
Sotera Health Company generated $276.59M in revenue during Q2 2024, up 11.45% compared to the previous quarter, and up 125.39% compared to the same period a year ago.
Sotera Health Company Revenue Breakdown
Sotera Health Company Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Service | $905.60M | $864.83M | $805.50M |
| Product | $143.69M | $138.86M | $125.98M |
Sotera Health Company's latest annual revenue breakdown by segment (product or service), as of Dec 23: Service (86.31%), and Product (13.69%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | $237.76M | $226.48M | $237.92M | $227.12M | $226.05M | $214.51M | $220.38M | $216.70M | $221.53M | $206.22M | $207.59M | $200.50M | $208.71M | $188.70M |
| Product | $38.84M | $21.70M | $72.32M | $36.06M | $29.23M | $6.08M | $31.21M | $32.00M | $45.11M | $30.54M | $33.66M | $25.66M | $43.21M | $23.45M |
Sotera Health Company's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Service (85.96%), and Product (14.04%).
Sotera Health Company Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| UNITED STATES | $590.97M | $579.02M | $527.91M |
| CANADA | $192.05M | $188.74M | $177.88M |
| Europe | $187.54M | $166.03M | $161.81M |
| Other Geographical Areas | $78.73M | $69.90M | $63.89M |
Sotera Health Company's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (56.32%), CANADA (18.30%), Europe (17.87%), and Other Geographical Areas (7.50%).
Sotera Health Company Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IQV | IQVIA | $14.98B | $3.81B |
| ICLR | ICON Public Limited Company | $8.12B | $2.09B |
| QGEN | Qiagen | $1.97B | $458.80M |
| MEDP | Medpace | $1.89B | $528.10M |
| RDNT | RadNet | $1.62B | $459.71M |
| SHC | Sotera Health Company | $1.05B | $276.59M |
| NEOG | Neogen | $924.22M | $228.81M |
| MYGN | Myriad Genetics | $678.40M | $191.90M |
| GTH | Genetron | $650.71M | $201.32M |
| BNR | Burning Rock Biotech | $537.43M | $125.62M |
| OLK | Olink AB (publ) | $169.91M | $28.59M |
| FONR | FONAR | $98.65M | $25.72M |
| XGN | Exagen | $52.55M | $15.06M |
| ACRS | Aclaris Therapeutics | $31.25M | $2.40M |
| SERA | Sera Prognostics | $306.00K | - |
SHC Revenue FAQ
What is Sotera Health Company’s yearly revenue?
Sotera Health Company's yearly revenue for 2023 was $1.05B, representing an increase of 4.54% compared to 2022. The company's yearly revenue for 2022 was $1B, representing an increase of 7.75% compared to 2021. SHC's yearly revenue for 2021 was $931.48M, representing an increase of 13.85% compared to 2020.
What is Sotera Health Company’s quarterly revenue?
Sotera Health Company's quarterly revenue for Q2 2024 was $276.59M, a 11.45% increase from the previous quarter (Q1 2024), and a 8.35% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $248.18M, a -20.00% decrease from the previous quarter (Q4 2023), and a 12.51% increase year-over-year (Q1 2023). SHC's quarterly revenue for Q4 2023 was $310.24M, a 17.88% increase from the previous quarter (Q3 2023), and a 23.31% increase year-over-year (Q4 2022).
What is Sotera Health Company’s revenue growth rate?
Sotera Health Company's revenue growth rate for the last 3 years (2021-2023) was 12.65%, and for the last 5 years (2019-2023) was 34.81%.
What are Sotera Health Company’s revenue streams?
Sotera Health Company's revenue streams in c 23 are Service, and Product. Service generated $905.6M in revenue, accounting 86.31% of the company's total revenue, up 4.71% year-over-year. Product generated $143.69M in revenue, accounting 13.69% of the company's total revenue, up 3.48% year-over-year.
What is Sotera Health Company’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Sotera Health Company was Service. This segment made a revenue of $905.6M, representing 86.31% of the company's total revenue.